Zhou Yujiao, Zhang Yuan, Guo Yang, Zhang Youyi, Xu Ming, He Bei
Department of Respiratory Medicine and Institute of Vascular Medicine, Peking University Third Hospital; Beijing Key Laboratory of Cardiovascular Receptors Research, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Beijing, People's Republic of China.
Department of Respiratory Medicine, Changji Renmin Hospital, Changji, Xinjiang, People's Republic of China.
PLoS One. 2014 Jun 6;9(6):e97788. doi: 10.1371/journal.pone.0097788. eCollection 2014.
Progression of chronic obstructive pulmonary disease is associated with small airway obstruction by accumulation of inflammatory mucous exudates. However, the mechanism of mucin hypersecretion after exposure to cigarette smoke (CS) is still not clear. In this study, we explored the contribution of β2-adrenoceptor (β2-AR) signaling to CS extract (CSE)-induced mucus hypersecretion in vitro and examined the effect of a β-blocker on airway mucin hypersecretion in vivo. NCI-H292 epithelial cell line was used to determine the contribution of β2-AR signaling to CSE-induced MUC5AC production by treatment with β2-AR antagonists propranolol and ICI118551 and β2-AR-targeted small interfering RNA. The effect of propranolol on airway mucus hypersecretion was examined in a rat model exposed to CS. MUC5AC expression was assayed by real-time PCR, immunohistochemistry and ELISA. β2-AR and its downstream signaling were detected by western blot analysis. We found that pretreating NCI-H292 cells with propranolol, ICI118551 for 30 min or β2AR-targeted siRNA for 48 h reduced MUC5AC mRNA and protein levels stimulated by CSE. However,inhibiting the classical β2AR-cAMP-PKA pathway didn't attenuate CSE-induced MUC5AC production, while silencing β-arretin2 expression significantly decreased ERK and p38MAPK phosphorylation, thus reduced the CSE-stimulated MUC5AC production. In vivo, we found that administration of propranolol (25 mg kg(-1) d(-1)) for 28 days significantly attenuated the airway goblet cell metaplasia, mucus hypersecretion and MUC5AC expression of rats exposed to CS. From the study, β2-AR-β-arrestin2-ERK1/2 signaling was required for CS-induced airway MUC5AC expression. Chronic propranolol administration ameliorated airway mucus hypersecretion and MUC5AC expression in smoking rats. The exploration of these mechanisms may contribute to the optimization of β2-AR target therapy in chronic obstructive pulmonary disease.
慢性阻塞性肺疾病的进展与炎症性黏液渗出物的积聚导致小气道阻塞有关。然而,接触香烟烟雾(CS)后黏蛋白分泌过多的机制仍不清楚。在本研究中,我们探讨了β2-肾上腺素能受体(β2-AR)信号传导对CS提取物(CSE)诱导的体外黏液分泌过多的作用,并研究了一种β受体阻滞剂对体内气道黏蛋白分泌过多的影响。使用NCI-H292上皮细胞系,通过用β2-AR拮抗剂普萘洛尔和ICI118551以及靶向β2-AR的小干扰RNA处理,来确定β2-AR信号传导对CSE诱导的MUC5AC产生的作用。在暴露于CS的大鼠模型中研究了普萘洛尔对气道黏液分泌过多的影响。通过实时PCR、免疫组织化学和ELISA检测MUC5AC表达。通过蛋白质印迹分析检测β2-AR及其下游信号传导。我们发现,用普萘洛尔、ICI118551预处理NCI-H292细胞30分钟或用靶向β2AR的siRNA预处理48小时可降低CSE刺激的MUC5AC mRNA和蛋白质水平。然而,抑制经典的β2AR-cAMP-PKA途径并未减弱CSE诱导的MUC5AC产生,而沉默β-arrestin2表达可显著降低ERK和p38MAPK磷酸化,从而减少CSE刺激的MUC5AC产生。在体内,我们发现给予普萘洛尔(25mg kg(-1) d(-1))28天可显著减轻暴露于CS的大鼠的气道杯状细胞化生、黏液分泌过多和MUC5AC表达。从该研究可知,CS诱导的气道MUC5AC表达需要β2-AR-β-arrestin2-ERK1/2信号传导。长期给予普萘洛尔可改善吸烟大鼠的气道黏液分泌过多和MUC5AC表达。对这些机制的探索可能有助于优化慢性阻塞性肺疾病中β2-AR靶向治疗。